In 2003, Pender M.P. et al. hypothesized that a defect in CD8+ T-cell control over EBV predisposes patients to MS, allowing EBV-infected autoreactive B cells and plasma cells to accumulate in the CNS [140]. This evidence concerns the gene CD8A and myeloid sarcoma.